Olin (OLN) Investor Day 2024 summary

Strategic direction and value creation

• Pursuing a disciplined value-first commercial strategy, optimizing and growing core businesses in chemicals and ammunition, and targeting high-return growth in adjacencies such as chlor alkali, PVC, and defense ammunition.

• Targeting over $250 million in structural cost savings by 2028 through cost reduction, asset optimization, and productivity initiatives across all segments.

• Growth initiatives include expanding in PVC via contract manufacturing and joint ventures, leveraging leading bleach positions, and exploring defense ammunition value chain opportunities.

• Sustainability targets raised: CO2 emissions reduction goal increased to 35% and water consumption reduction to 25% by 2028/2030, enabled by operational efficiencies and technology upgrades.

• Strategy underpinned by disciplined capital allocation, prioritizing shareholder returns, maintaining investment-grade credit ratings, and a leadership team with deep industry experience.

Financial guidance and long-term targets

• 2029 targets: Adjusted EBITDA of ~$2 billion, >$250 million structural cost savings by 2028, 85%+ cash conversion, and >50% of operating cash flow returned to shareholders (2025–2029 average).

• Committed to maintaining net debt/EBITDA below 2.0x and investment grade credit ratings.

• Capital spending to average ~$250 million annually, with all major growth projects required to exceed a 15% IRR and compete with share repurchases.

• Share repurchase authorization increased to ~$2 billion, with a track record of returning ~47% of operating cash flows to shareholders since 2015.

• No change in Q4 2024 guidance; expect to be at the low end of $170–$200 million Adjusted EBITDA range due to Hurricane Beryl impact.

Business segment outlooks

• Chlor Alkali Products and Vinyls (CAPV) aims for ~$1.5 billion adjusted mid-cycle EBITDA by 2029, driven by cost savings, market recovery, and incremental EBITDA from PVC contract manufacturing.

• Epoxy targets ~$150 million adjusted EBITDA by 2029, with $80 million in structural cost savings and incremental EBITDA from formulated solutions aligned with megatrends like energy transition and electronics.

• Winchester expects ~$450 million adjusted EBITDA by 2029, with $30 million in cost savings and growth from defense and commercial markets, plus upside from GOCO contract wins and new product development.

• Each segment is focused on asset optimization, efficiency, and leveraging integrated value chains for growth.

• Expanding defense participation through cross-business collaboration in chemicals and energetics.